NCT02981355 - Randomized Evaluation of BST-CarGel Versus Microfracture Alone On Recovery From Distal Femoral Cartilage Lesions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 26, 2017

Primary Completion Date

March 6, 2018

Study Completion Date

March 6, 2018

Conditions

Traumatic; LesionDegenerative Lesion of Articular Cartilage of Knee

Interventions

PROCEDURE

Microfracture treatment

Microfracture is performed by penetrating the subchondral bone beneath the cartilage lesion inducing a bleeding response.

DEVICE

BST-CarGel

BST-CarGel is combined with fresh, autologous whole blood and applied to the lesion on the femoral condyle with a syringe following microfracture arthroscopic surgery.

Trial Locations (15)

5000

Calvary Wakefield Hospital, Adelaide

6150

Murdoch Orthopaedic Clinic, Murdoch

8032

SportClinic Zurich / Hirslanden Clinic, Zurich

50009

Hospital Universitario Miguel Servet, Zaragoza

54000

CHRU Nancy - Hospital Central, Nancy

69004

Hopital de La Croix-Rousse, Lyon

93042

University Medical Centre Regensburg, Regensburg

T1L1B3

Banff Sport Medicine, Banff

N6A3K7

Fowler Kennedy Sport Medicine Clinic, London

H1T4B3

Hôpital Maisonneuve-Rosemont, Montreal

08003

Hospital Universitari del Mar, Barcelona

08023

Hospital Quironsalud Barcelona, Barcelona

08035

Hospital Universitari Vall d'Hebron, Barcelona

B312AP

The Royal Orthopaedic Hospital, Birmingham

S0166YD

University Hospital Southampton, Southampton